https://doi.org/10.1016/j.drugpo.2016.05.010
M
Michael Otterstatter
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
3.0K
Citations
26
h-index
46
i10-index
Michael Otterstatter is an academic researcher from Emmes (United States). The author has contributed to research in topics: COVID-19 epidemiological studies & Plant and animal studies & Opioid Use Disorder Treatment. The author has an h-index of 26, co-authored 87 publications.
ORCID: 0000-0001-5489-014XPapers by this author
worksIllicit drug overdose deaths resulting from income assistance payments: Analysis of the ‘check effect’ using daily mortality data
2016 · International Journal of Drug Policy · 35 citations
Mathematical modeling of COVID-19 in British Columbia: An age-structured model with time-dependent contact rates
2022 · Epidemics · 25 citations
https://doi.org/10.1016/j.epidem.2022.100559
How much leeway is there to relax COVID-19 control measures?
2021 · Epidemics · 18 citations
https://doi.org/10.1016/j.epidem.2021.100453
Quantifying Contact Patterns: Development and Characteristics of the British Columbia COVID-19 Population Mixing Patterns Survey
2022 · International Journal of Infectious Diseases · 4 citations
https://doi.org/10.1016/j.ijid.2021.12.073
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)
2025 · Contemporary Clinical Trials · 3 citations
https://doi.org/10.1016/j.cct.2025.107816
Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction services
2025 · BMJ Open · 1 citations
https://doi.org/10.1136/bmjopen-2024-090704
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat